European Primary Care Cardiovascular Society

Update on managing CV risk in diabetes: what's the evidence?

EPCCS Annual CV Summit

5' education - Mar. 22, 2019 - Lisbon, Portugal - Kamlesh Khunti & Richard Hobbs

Video navigation menu

  • The relevance of CV risk in diabetes 0:23
  • What can be done to mitigate the CV risk associated with diabetes? 1:28
  • Is the evidence on new means to lower CV risk in diabetes implemented in practice? 2:31
  • Barriers to implementation of the evidence 3:29
  • It's time to discuss a new concept: quaternary prevention or de-intensification of therapy 4:17

Educational information

This video was recorded during the two-day EPCCS CV Summit and aims to give an impression of the presentation given by prof. Khunti.

Faculty

Professor Kamlesh Khunti is head of Department and Professor of Primary Care Diabetes and Vascular Medicine, at the Diabetes Research Centre, University of Leicester, Leiceister, UK.

Professor Richard Hobbs, MD - Professor and Head of the Department of Primary Health Care- Nuffield Department of Primary Care Health Science - University of Oxford, Oxford, UK. Prof. Hobbs is chairman of EPCCS.

Disclosures

This recording was independently developed under auspices of EPCCS. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of EPCCS. No funding was obtained for the recording of this video.

View the slides of the presentation of prof. Khunti View the slides of the introductory presentation on the topic by prof. Hobbs

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: